Treatment of brain metastases of malignant melanoma with temozolomide [5]

New England Journal of Medicine

Volumn 345, Issue 8, 2001, Pages 621-622

  Biasco, G ^a   Pantaleo, M A ^a   Casadei, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; DACARBAZINE; INTERLEUKIN 2; TEMOZOLOMIDE;

ADULT; BRAIN CANCER; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; HUMAN; LETTER; LUNG METASTASIS; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; DACARBAZINE; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0035940041     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200108233450817     Document Type: Letter

References (4)

1. Randomized phase III study oftemozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
2. Pharmacokinetic study of temozolomide penetration into CSF in a patient with dural melanoma
3. Temozolomide - A promising agent in the therapy of brain metastases in malignant melanoma